Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01151020 · ClinicalTrials.gov registry record · NA
TX2® Low Profile TAA Endovascular Graft
A NA study, sponsored by Cook Research Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT01151020 is a NA study that has completed, run by Cook Research Incorporated. The registered enrollment target is 110 participants.
The verdict
NCT01151020, a NA study, has completed, sponsored by Cook Research Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
The Zenith® TX2® Low Profile TAA Endovascular Graft study is a clinical trial approved by US FDA to evaluate the safety and effectiveness of the Zenith® TX2® Low Profile TAA Endovascular Graft indicated for the treatment of patients with aneurysms/ulcers of the descending thoracic aorta having vessel structure suitable for repair.
Interventions
- DEVICE Zenith® TX2® Low Profile TAA Endovascular Graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2010-03 |
| Est. Completion | 2018-05-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01151020
The ClinicalTrials.gov registry entry for NCT01151020 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Research Incorporated, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zenith® TX2® Low Profile TAA Endovascular Graft is the first listed.
NCT01151020 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01151020 about?
NCT01151020 is a clinical study titled "TX2® Low Profile TAA Endovascular Graft". The Zenith® TX2® Low Profile TAA Endovascular Graft study is a clinical trial approved by US FDA to evaluate the safety and effectiveness of the Zenith® TX2® Low Profile TAA Endovascular Graft indicated for the treatment of patients with aneurysms/ulcers of the descending thoracic aorta having vesse...
What is the current status of trial NCT01151020?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2010-03. Estimated completion is 2018-05-11.
What interventions are being tested in trial NCT01151020?
The interventions under investigation include: Zenith® TX2® Low Profile TAA Endovascular Graft (DEVICE).
Who is sponsoring clinical trial NCT01151020?
This trial is sponsored by Cook Research Incorporated, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.